Market research
DXRX.LSE Diaceutics PLC
LSE GBP Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 118M
- P/E ratio
- 0.0
- Analyst target
- 213
- Dividend yield
- Not available
- Beta
- 0.89
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- GB00BJQTGV64
- Market cap
- 118M
- P/E ratio
- 0.0
- Analyst target
- 213
- Dividend yield
- Not available
- Beta
- 0.89
About
About Diaceutics PLC
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, that enables potential therapy eligibility for patients within hours of a diagnostic event, enabling teams to act while treatment decisions are still pending; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers scientific and advisory services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the DXRX.LSE discussion.
5 years, 5 months ago
Diaceutics PLC is currently in a long term downtrend where the price is trading 2.2% below its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.3.
Diaceutics PLC's total revenue sank by 0.0% to $5M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $1M since the same quarter in the previous year.
Finally, its free cash flow fell by 214.2% to $-543K since the same quarter in the previous year.
Based on the above factors, Diaceutics PLC gets an overall score of 1/5.